[1]
Chesang, J. 2017. Use of oral contraceptives, depot medroxyprogesterone acetate and intrauterine contraceptive devices and the risk of cancer. Journal of Obstetrics and Gynaecology of Eastern and Central Africa. 29, 1 (Jun. 2017), 11–16. DOI:https://doi.org/10.59692/jogeca.v29i1.351.